甲状腺功能测试市场规模、份额和成长分析（按类型、最终用户和地区）：产业预测（2024-2031）

2022年全球甲状腺功能检测市场规模为11亿美元，从2023年的12亿美元成长到2031年的24.5亿美元，预计复合年增长率为9.3%。

由于格雷夫兹病和桥本甲状腺炎等甲状腺疾病的盛行率不断增加，甲状腺功能检测市场预计将显着成长。由于老年人口的不断增加和甲状腺健康意识的增强，对这些血液检测的需求预计将激增。实验室（包括医院和实验室）严重依赖这些测试，这些测试测量重要的荷尔蒙水平，如 TSH、T4、T3 和游离4碘甲状腺素。久坐的生活方式、过量饮酒以及自体免疫疾病和糖尿病发病率上升等因素进一步推动了市场扩张。此外，主要产业参与者之间开发创新检测方法的策略联盟将支持成长。总体而言，美国甲状腺功能检测市场预计未来几年将维持强劲的复合年增长率。

目录

介绍

• 分析目的
• 市场范围
• 定义

分析方法

• 资讯采购
• 次要/主要资料方法
• 市场规模预测
• 市场假设与约束

执行摘要

• 市场概况及展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及前景

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 抑制因素和挑战
• 波特的分析

主要市场考虑因素

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场魅力指数（2023）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 价格分析

全球甲状腺功能测试市场规模和复合年增长率：按类型（2024-2031）

• 市场概况
• 促甲状腺激素测试
• T4测试
• T3测试
• 其他测试

全球甲状腺功能测试市场规模和复合年增长率：按最终用户划分（2024-2031）

• 市场概况
• 医院
• 诊断实验室
• 检验室/实验室
• 其他最终用户

全球甲状腺功能检测市场规模/复合年增长率（2024-2031）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争格局

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要企业采取的策略
• 近期市场趋势
• 主要企业市场占有率（2023年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2021-2023）

主要企业简介

• 赛默飞世尔科技（美国）
• 雅培实验室（美国）
• 罗氏诊断（瑞士）
• 丹纳赫公司（美国）
• 迪亚索林（义大利）
• 西门子医疗（德国）
• 默克公司（德国）
• Bio-Rad 实验室（美国）
• Ortho 临床诊断（美国）
• 贝克曼库尔特（美国）
• F. Hoffmann-La Roche Ltd.（瑞士）
• 奎德尔奥索（美国）
• 伊诺瓦诊断公司（美国）
• 积水诊断（美国）
• Trinity Biotech（爱尔兰）
• ARUP实验室（美国）
• 奎斯特诊断（美国）
• 美国实验室控股公司（美国）
• Eurofins Scientific（卢森堡）
• MSD（默克公司）（美国）

结论和建议

Global Thyroid Function Test Market size was valued at USD 1.1 billion in 2022 and is poised to grow from USD 1.2 billion in 2023 to USD 2.45 billion by 2031, growing at a CAGR of 9.3% during the forecast period (2024-2031).

The Thyroid Function Test market is poised for significant growth, driven by an increasing prevalence of thyroid disorders such as Graves' disease and Hashimoto's thyroiditis. With a rising geriatric population and heightened awareness of thyroid health, demand for these blood tests is anticipated to surge. Healthcare sectors, including hospitals and research laboratories, rely heavily on these tests, which measure vital hormone levels like TSH, T4, T3, and free T4. Contributing factors such as sedentary lifestyles, excessive alcohol consumption, and the rise of autoimmune disorders and diabetes further underpin market expansion. Additionally, strategic collaborations among key industry players aimed at developing innovative detection methods will bolster growth. Overall, the U.S. Thyroid Function Test market is projected to sustain a robust CAGR in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Thyroid Function Test market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Thyroid Function Test Market Segmental Analysis

Global Thyroid Function Test Market is segmented by type, end user and region. Based on type, the market is segmented into TSH tests, t4 tests, t3 tests and other tests. Based on end user, the market is segmented into hospitals, diagnostic laboratories, research laboratories & institutes and other end users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Thyroid Function Test Market

The global market for thyroid function tests is anticipated to experience significant growth due to the rising incidence of thyroid cancers coupled with the pressing demand for affordable diagnostic solutions. As more individuals seek effective screening methods for thyroid disorders, the market is further propelled by increased government funding aimed at enhancing healthcare infrastructure in both developed and emerging countries. Additionally, the swift evolution of lifestyle factors contributing to thyroid health emphasizes the critical need for such tests. Collectively, these factors are set to stimulate advancements and expansions within the thyroid function test market throughout the forecast period.

Restraints in the Global Thyroid Function Test Market

The Global Thyroid Function Test (GTFT) is a comprehensive assessment that evaluates the hormonal activity and regulatory mechanisms of the thyroid gland through a singular, integrative approach. Its primary restraint lies in the potential for false positives or negatives, influenced by individual variations in thyroid hormone metabolism, concurrent illnesses, or medications that may interfere with thyroid function. Additionally, GTFT may not specifically identify the nuances of certain thyroid disorders, leading to misinterpretation of results. Consequently, it should be interpreted in conjunction with clinical evaluations and additional diagnostic tests to ensure accurate assessment and effective management of thyroid-related conditions.

Market Trends of the Global Thyroid Function Test Market

The global thyroid function test market is witnessing a significant trend towards point-of-care testing, driven by the demand for convenience and faster results. This shift allows for immediate diagnosis and ongoing monitoring of thyroid disorders, enhancing patient management and treatment outcomes. By enabling tests to be conducted outside traditional laboratory settings, point-of-care testing reduces the waiting period for results, thus improving accessibility for patients. As healthcare providers prioritize efficient diagnostic solutions, the adoption of portable, user-friendly devices is expected to rise, further propelling market growth. This trend reflects a broader movement towards personalized medicine and streamlined healthcare delivery.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Thyroid Function Test Market Size by Type & CAGR (2024-2031)

• Market Overview
• TSH Tests
• T4 Tests
• T3 Tests
• Other Tests

Global Thyroid Function Test Market Size by End User & CAGR (2024-2031)

• Market Overview
• Hospitals
• Diagnostic Laboratories
• Research Laboratories & Institutes
• Other End Users

Global Thyroid Function Test Market Size & CAGR (2024-2031)

• North America (Type, End User)
  • US
  • Canada
• Europe (Type, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Thermo Fisher Scientific (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaSorin (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ortho Clinical Diagnostics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QuidelOrtho (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inova Diagnostics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sekisui Diagnostics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trinity Biotech (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ARUP Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quest Diagnostics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Laboratory Corporation of America Holdings (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MSD (Merck & Co.) (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations